Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,693 INR | -1.39% | -1.06% | -12.03% |
05-07 | Gland Pharma Gets US FDA's Approval for Generic ALS Drug | MT |
05-07 | Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.03% | 3.39B | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Nomura Upgrades Gland Pharma to Neutral From Reduce, Adjusts Price Target to INR1,570 From INR1,157